These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 29785777)

  • 41. ICAM5 as a Novel Target for Treating Cognitive Impairment in Fragile X Syndrome.
    Pei YP; Wang YY; Liu D; Lei HY; Yang ZH; Zhang ZW; Han M; Cheng K; Chen YS; Li JQ; Cheng GR; Xu L; Wu QM; McClintock SM; Yang Y; Zhang Y; Zeng Y
    J Neurosci; 2020 Feb; 40(6):1355-1365. PubMed ID: 31882402
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activity-dependent regulation of release probability at excitatory hippocampal synapses: a crucial role of fragile X mental retardation protein in neurotransmission.
    Wang XS; Peng CZ; Cai WJ; Xia J; Jin D; Dai Y; Luo XG; Klyachko VA; Deng PY
    Eur J Neurosci; 2014 May; 39(10):1602-12. PubMed ID: 24646437
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adenosine A
    Ferrante A; Boussadia Z; Borreca A; Mallozzi C; Pedini G; Pacini L; Pezzola A; Armida M; Vincenzi F; Varani K; Bagni C; Popoli P; Martire A
    Transl Psychiatry; 2021 Feb; 11(1):112. PubMed ID: 33547274
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endocannabinoid-mediated improvement on a test of aversive memory in a mouse model of fragile X syndrome.
    Qin M; Zeidler Z; Moulton K; Krych L; Xia Z; Smith CB
    Behav Brain Res; 2015 Sep; 291():164-171. PubMed ID: 25979787
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reduced phenotypic severity following adeno-associated virus-mediated Fmr1 gene delivery in fragile X mice.
    Gholizadeh S; Arsenault J; Xuan IC; Pacey LK; Hampson DR
    Neuropsychopharmacology; 2014 Dec; 39(13):3100-11. PubMed ID: 24998620
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Behavioral Phenotype of Fmr1 Knock-Out Mice during Active Phase in an Altered Light/Dark Cycle.
    Saré RM; Levine M; Smith CB
    eNeuro; 2016; 3(2):. PubMed ID: 27294193
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fragile X mice have robust mGluR5-dependent alterations of social behaviour in the Automated Tube Test.
    de Esch CE; van den Berg WE; Buijsen RA; Jaafar IA; Nieuwenhuizen-Bakker IM; Gasparini F; Kushner SA; Willemsen R
    Neurobiol Dis; 2015 Mar; 75():31-9. PubMed ID: 25562659
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Selective Disruption of Metabotropic Glutamate Receptor 5-Homer Interactions Mimics Phenotypes of Fragile X Syndrome in Mice.
    Guo W; Molinaro G; Collins KA; Hays SA; Paylor R; Worley PF; Szumlinski KK; Huber KM
    J Neurosci; 2016 Feb; 36(7):2131-47. PubMed ID: 26888925
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Brief report: altered social behavior in isolation-reared Fmr1 knockout mice.
    Heitzer AM; Roth AK; Nawrocki L; Wrenn CC; Valdovinos MG
    J Autism Dev Disord; 2013 Jun; 43(6):1452-8. PubMed ID: 23015112
    [TBL] [Abstract][Full Text] [Related]  

  • 50. FMRP regulation of aggrecan mRNA translation controls perineuronal net development.
    Van't Spijker HM; Richter JD
    J Neurochem; 2024 Sep; 168(9):1909-1922. PubMed ID: 38225196
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Audiogenic Seizures in the
    Gonzalez D; Tomasek M; Hays S; Sridhar V; Ammanuel S; Chang CW; Pawlowski K; Huber KM; Gibson JR
    J Neurosci; 2019 Dec; 39(49):9852-9863. PubMed ID: 31666356
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reelin central fragment supplementation improves cognitive deficits in a mouse model of Fragile X Syndrome.
    Morrill NK; Joly-Amado A; Li Q; Prabhudeva S; Weeber EJ; Nash KR
    Exp Neurol; 2022 Nov; 357():114170. PubMed ID: 35863501
    [TBL] [Abstract][Full Text] [Related]  

  • 53. AAV-delivered diacylglycerol kinase DGKk achieves long-term rescue of fragile X syndrome mouse model.
    Habbas K; Cakil O; Zámbó B; Tabet R; Riet F; Dembele D; Mandel JL; Hocquemiller M; Laufer R; Piguet F; Moine H
    EMBO Mol Med; 2022 May; 14(5):e14649. PubMed ID: 35373916
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The feasibility and utility of hair follicle sampling to measure FMRP and FMR1 mRNA in children with or without fragile X syndrome: a pilot study.
    Jalnapurkar I; Frazier JA; Roth M; Cochran DM; Foley A; Merk T; Venuti L; Ronco L; Raines S; Cadavid D
    J Neurodev Disord; 2022 Dec; 14(1):57. PubMed ID: 36494616
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The state of synapses in fragile X syndrome.
    Pfeiffer BE; Huber KM
    Neuroscientist; 2009 Oct; 15(5):549-67. PubMed ID: 19325170
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-lasting effects of minocycline on behavior in young but not adult Fragile X mice.
    Dansie LE; Phommahaxay K; Okusanya AG; Uwadia J; Huang M; Rotschafer SE; Razak KA; Ethell DW; Ethell IM
    Neuroscience; 2013 Aug; 246():186-98. PubMed ID: 23660195
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fragile X mental retardation protein regulates heterosynaptic plasticity in the hippocampus.
    Connor SA; Hoeffer CA; Klann E; Nguyen PV
    Learn Mem; 2011; 18(4):207-20. PubMed ID: 21430043
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Behavioral effects of chronic stress in the Fmr1 mouse model for fragile X syndrome.
    Lemaire-Mayo V; Subashi E; Henkous N; Beracochea D; Pietropaolo S
    Behav Brain Res; 2017 Mar; 320():128-135. PubMed ID: 27939692
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lithium reverses increased rates of cerebral protein synthesis in a mouse model of fragile X syndrome.
    Liu ZH; Huang T; Smith CB
    Neurobiol Dis; 2012 Mar; 45(3):1145-52. PubMed ID: 22227453
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The small GTPase Arf6 is dysregulated in a mouse model for fragile X syndrome.
    Briševac D; Scholz R; Du D; Elagabani MN; Köhr G; Kornau HC
    J Neurochem; 2021 May; 157(3):666-683. PubMed ID: 33125726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.